USE OF NOGO RECEPTOR-1 (NGR1) ANTAGONISTS FOR PROMOTING OLIGODENDROCYTE SURVIVAL

摘要

The invention provides methods of treating diseases, disorders or injuries involving oligodendrocyte death, demyelination and dysmyelination, including spinal cord injury, by the administration of an NgR1 antagonist.